Analyses of Patient-Reported Outcomes (PROs) With Mirvetuximab Soravtansine (MIRV) Versus Standard Chemotherapy in the Randomized Phase 3 FORWARD I Study in Ovarian Cancer (GOG 3011)
Mirvetuximab Soravtansine
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Analyses of Patient-Reported Outcomes (PROs) With Mirvetuximab Soravtansine (MIRV) Versus Standard Chemotherapy in the Randomized Phase 3 FORWARD I Study in Ovarian Cancer (GOG 3011) ### Output: Mirvetuximab Soravtansine